Nasdaq trade halt continues; news pending at 3:28 a.m.
COCH•Nasdaq continued a trading halt, with news pending at 3:28 a.m.
Related News
AstraZeneca’s Imfinzi-tarlatamab combination cuts death risk 58% in Phase III lung cancer trial
AZN•
Nasdaq trade halt continues, halt news pending at 03:28 am
SBFM•
BioNTech and Bristol Myers Squibb report phase 2 pumitamig data after immunotherapy-chemo progression in advanced NSCLC
BNTX•
Nanobiotix reports 41.7% response rate in Phase 1 trial of NBTXR3 combination in anti-PD-1-resistant melanoma
NBTX•
Semtech demonstrates 5G network slicing at IACP conference
SMTC•